Zebrafish |
Molecular mechanisms of sleep/wake rhythm |
Low cost; high gene-editing efficiency and relatively well-defined behavioral phenotypes |
Not yet evaluated for depression-related sleep disturbances |
(47–57) |
Cat |
Neuroendocrine mechanisms of sleep and sleep deprivation |
Quantitative research of neurotransmitters |
Not yet evaluated for depression and depression-related sleep disturbances |
(58–60) |
Dog |
Sleep-wake cycle; narcolepsy; geriatric insomnia; obstructive sleep apnoea; sleep-associated epilepsy; and REMs disorder |
Shared risks of many sleep disturbances with humans |
More variable and fragmented sleep pattern; not yet evaluated for depression; and depression-related sleep disturbances |
(61–67) |
Rodents |
Depression and sleep homeostasis; sleep structure; sleep-wake cycle; neurotransmitter receptor sensitivity and neuroendocrine stress response; as well as the effects of antidepressants on sleep |
Low cost; easy to manipulate and gene-editing |
Nocturnal animals; shorter durations of REMs and NREMs cycles |
(68–82) |
Non-human primates |
Sleep-related neurobiology; neuroendocrine; and behavioral pharmacological studies |
Highly similar to humans in brain structure, behavior, metabolism, sleep characteristics, and circadian rhythms |
Difficult to directly measure mood or thoughts; limited behavioral screening tools; and lack of the effects of antidepressants on sleep |
(83–97) |